Q3679109 (Q3679109): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: importing one item from France) |
(Created claim: summary (P836): The NanoMedesil project aims to exploit the unique properties of porous silicon, one of the few bioresorbable and non-toxic nanomaterials, to develop systems for medical imaging, targeted anti-tumor therapy and tissue regeneration in the treatment of cancer. This project is based on an innovative research approach and is likely to generate product innovation, through the clinical application of therapeutic nano-tools developed at preclinical l...) |
||||||||||||||
| Property / summary | |||||||||||||||
The NanoMedesil project aims to exploit the unique properties of porous silicon, one of the few bioresorbable and non-toxic nanomaterials, to develop systems for medical imaging, targeted anti-tumor therapy and tissue regeneration in the treatment of cancer. This project is based on an innovative research approach and is likely to generate product innovation, through the clinical application of therapeutic nano-tools developed at preclinical level and the development of a new advanced medical product. (English) | |||||||||||||||
| Property / summary: The NanoMedesil project aims to exploit the unique properties of porous silicon, one of the few bioresorbable and non-toxic nanomaterials, to develop systems for medical imaging, targeted anti-tumor therapy and tissue regeneration in the treatment of cancer. This project is based on an innovative research approach and is likely to generate product innovation, through the clinical application of therapeutic nano-tools developed at preclinical level and the development of a new advanced medical product. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The NanoMedesil project aims to exploit the unique properties of porous silicon, one of the few bioresorbable and non-toxic nanomaterials, to develop systems for medical imaging, targeted anti-tumor therapy and tissue regeneration in the treatment of cancer. This project is based on an innovative research approach and is likely to generate product innovation, through the clinical application of therapeutic nano-tools developed at preclinical level and the development of a new advanced medical product. (English) / qualifier | |||||||||||||||
point in time: 18 November 2021
| |||||||||||||||
Revision as of 16:41, 18 November 2021
Project Q3679109 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3679109 in France |
Statements
59,500.0 Euro
0 references
88,835.0 Euro
0 references
66.98 percent
0 references
20 November 2015
0 references
30 June 2018
0 references
CNRS Délégation Languedoc Roussillon
0 references
Le projet NanoMedesil vise à exploiter les propriétés particulières du silicium poreux, qui est l'un des rares nanomatériaux bio résorbable et non toxique, afin d'élaborer des systèmes utilisables en imagerie médicale, en thérapie anti-tumorale ciblée et pour la régénération tissulaire dans le traitement du cancer. Ce projet s'appuie sur une démarche de recherche innovante et est susceptible de générer une innovation de produit, à travers l'application clinique des nano-outils thérapeutiques développés au niveau préclinique et l'élaboration d'un nouveau produit médical avancé. (French)
0 references
The NanoMedesil project aims to exploit the unique properties of porous silicon, one of the few bioresorbable and non-toxic nanomaterials, to develop systems for medical imaging, targeted anti-tumor therapy and tissue regeneration in the treatment of cancer. This project is based on an innovative research approach and is likely to generate product innovation, through the clinical application of therapeutic nano-tools developed at preclinical level and the development of a new advanced medical product. (English)
18 November 2021
0 references
Identifiers
LR0001323
0 references